Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000006 per share
-
Shares outstanding
-
1.09B
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
39.1M
-
Shares change
-
-3.35M
-
Total reported value, excl. options
-
$949M
-
Value change
-
-$90.8M
-
Put/Call ratio
-
6.84
-
Number of buys
-
49
-
Number of sells
-
-76
-
Price
-
$24.31
Significant Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q3 2023
149 filings reported holding ZLAB - Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share as of Q3 2023.
Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.1M shares
of 1.09B outstanding shares and own 3.58% of the company stock.
Largest 10 shareholders include Capital World Investors (5.22M shares), JANUS HENDERSON GROUP PLC (4.24M shares), Invesco Ltd. (3.21M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.72M shares), VIKING GLOBAL INVESTORS LP (2.49M shares), WELLINGTON MANAGEMENT GROUP LLP (1.92M shares), Segantii Capital Management Ltd (1.79M shares), BAMCO INC /NY/ (1.58M shares), FMR LLC (1.27M shares), and Rock Springs Capital Management LP (1.24M shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.